Target intelligence / Profile preview

USP34 divergent transcript (USP34-DT)

Target: USP34-DT
Molecular classification: Long non-coding RNA (lncRNA), Divergent transcript

Overview

USP34 divergent transcript (USP34-DT) is a human long non-coding RNA gene located near the protein coding gene USP34 on chromosome 2[1][2]. It is classified as a divergent transcript—a type of lncRNA situated within 300–500 nucleotides of a protein-coding gene and transcribed in the opposite direction[2]. There is currently no evidence it encodes a protein, nor is it a recognized druggable therapeutic target such as a receptor, enzyme, or transporter[1][2]. No known biological functions, disease associations, drug interactions, mechanisms of action, biomarkers, or safety concerns have been described for USP34-DT to date[1][2].

Other names: USP34-DTAC016727.1

Beyond the preview

Go deeper on USP34 divergent transcript (USP34-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on USP34 divergent transcript (USP34-DT).

Explore the full profile